Restless Legs Syndrome: A Common Disorder in Patients with Rheumatologic Conditions

Seminars in Arthritis and Rheumatism

Volumn 38, Issue 1, 2008, Pages 55-62

  Hening, Wayne A ^a   Caivano, Christine K ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

diagnosis; restless legs syndrome; rheumatic; RLS; treatment

Indexed keywords

BENZODIAZEPINE; CLONAZEPAM; CODEINE; DEXTROPROPOXYPHENE; GABAPENTIN; HYDROCODONE; LEVODOPA; METHADONE; OXYCODONE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; TEMAZEPAM; TRIAZOLAM; ZOLPIDEM;

ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DIZZINESS; DRUG SAFETY; DRUG TOLERABILITY; FIBROMYALGIA; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; LEG MOVEMENT; LEG PAIN; LOW DRUG DOSE; NAUSEA; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY OF LIFE; REBOUND; RESTLESS LEGS SYNDROME; RHEUMATOID ARTHRITIS; SCLERODERMA; SIDE EFFECT; SJOEGREN SYNDROME; SLEEP DISORDER; UNPLEASANT SENSATION;

FEMALE; HUMANS; MALE; RESTLESS LEGS SYNDROME; RHEUMATIC DISEASES;

EID: 47249105615     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2007.09.001     Document Type: Article

References (72)

1. Hening W.A. Restless legs syndrome: a sensorimotor disorder of sleep/wake motor regulation. Curr Neurol Neurosci Rep 2 (2002) 186-196
2. Allen R.P., and Earley C.J. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol 18 (2001) 128-147
3. Allen R.P., Walters A.S., Montplaisir J., Hening W., Myers A., Bell T.J., et al. Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 165 (2005) 1286-1292
4. Hening W., Walters A.S., Allen R.P., Montplaisir J., Myers A., and Ferini-Strambi L. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 5 (2004) 237-246
5. Reynolds G., Blake D.R., Pall H.S., and Williams A. Restless leg syndrome and rheumatoid arthritis. Br Med J (Clin Res Ed) 292 (1986) 659-660
6. Salih A.M., Gray R.E., Mills K.R., and Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol 33 (1994) 60-63
7. Yunus M.B., and Aldag J.C. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ 312 (1996) 1339
8. Garcia-Borreguero D., Egatz R., Winkelmann J., and Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 10 (2006) 153-167
9. Kirwan J.R., and Snow S.M. Which patients see a rheumatologist?. SWRACR (South Western Regional Advisory Committee on Rheumatology). Br J Rheumatol 30 (1991) 285-287
10. Banno K., Delaive K., Walld R., and Kryger M.H. Restless legs syndrome in 218 patients: associated disorders. Sleep Med 1 (2000) 221-229
11. Berger K., Luedemann J., Trenkwalder C., John U., and Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 164 (2004) 196-202
12. Tison F., Crochard A., Leger D., Bouee S., Lainey E., and El H. Epidemiology of restless legs syndrome in French adults: the INSTANT study. Neurology 65 (2005) 239-246
13. Rutkove S.B., Matheson J.K., and Logigian E.L. Restless legs syndrome in patients with polyneuropathy. Muscle Nerve 19 (1996) 670-672
14. Ondo W., Tan E.K., and Mansoor J. Rheumatologic serologies in secondary restless legs syndrome. Mov Disord 15 (2000) 321-323
15. Gemignani F., Brindani F., Vitetta F., Marbini A., and Calzetti S. Restless legs syndrome in diabetic neuropathy: a frequent manifestation of small fiber neuropathy. J Periph Nerv Syst 12 (2007) 50-53
16. Gemignani F., and Brindani F. Restless legs syndrome associated with peripheral neuropathy. Eur J Neurol 14 (2007) e9-e10
17. Tayag-Kier C.E., Keenan G.F., Scalzi L.V., Schultz B., Elliott J., Zhao R.H., et al. Sleep and periodic limb movement in sleep in juvenile fibromyalgia. Pediatrics 106 (2000) e70
18. Montplaisir J., Boucher S., Poirier G., Lavigne G., Lapierre O., and Lesperance P. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov Disord 12 (1997) 61-65
19. Desautels A., Turecki G., Montplasir J., Sequeira A., Verner A., and Rouleau G.A. Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet 69 (2001) 1266-1270
20. Bonati M.T., Ferini-Strambi L., Aridon P., Oldani A., Zucconi M., and Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 126 (2003) 1485-1492
21. Stefansson H., Rye D.B., Hicks A., Petursson H., Ingasson A., Thorgeirsson T.E., et al. A genetic risk factor for periodic limb movements in sleep. New Engl J Med 357 (2007) 639-647
22. Gudbjornsson B., Broman J.E., Hetta J., and Hallgren R. Sleep disturbances in patients with primary Sjogren's syndrome. Br J Rheumatol 32 (1993) 1072-1076
23. Prado G.F., Allen R.P., Trevisani V.M., Toscano V.G., and Earley C.J. Sleep disruption on systemic sclerosis (scleroderma) patients: clinical and polysomnographic findings. Sleep Med 3 (2002) 341-345
24. Dominick K.L., Ahern F.M., Gold C.H., and Heller D.A. Health-related quality of life among older adults with arthritis. Health Qual Life Outcomes 2 (2004) 5
25. Drewes A.M., Jennum P., Andreasen A., Sjol A., and Neilson K. Self-reported sleep disturbances and daytime complaints in women with fibromyalgia and rheumatoid arthritis. J Musculoskel Pain 2 (1994) 15-31
26. Allen R., Picchietti D., Hening W.A., Trenkwalder C., Walters A.S., and Montplaisir J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 4 (2003) 101-119
27. Abetz L., Allen R., Follet A., Washburn T., Earley C., Kirsch J., et al. Evaluating the quality of life of patients with restless legs syndrome. Clin Ther 26 (2004) 925-935
28. Winkelmann J., Muller-Myhsok B., Wittchen H.U., Hock B., Prager M., Pfister H., et al. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 52 (2002) 297-302
29. Winkelmann J., Schormair B., Lichtner P., Ripke S., Xiong L., Jalilzadeh S., et al. Genome-wide association study in restless legs syndrome identifies common variants in three genomic regions. Nat Genet 39 (2007) 1000-1006
30. O'Keeffe S.T., Gavin K., and Lavan J.N. Iron status and restless legs syndrome in the elderly. Age Ageing 23 (1994) 200-203
31. Manconi M., Govoni V., De Vito A., Economou N.T., Cesnik E., Casetta I., et al. Restless legs syndrome and pregnancy. Neurology 63 (2004) 1065-1069
32. Wetter T.C., Stiasny K., Kohnen R., Oertel W.H., and Trenkwalder C. Polysomnographic sleep measures in patients with uremic and idiopathic restless legs syndrome. Mov Disord 13 (1998) 820-824
33. Manconi M., Fabbrini M., Bonnani E., Filippi M., Rocca M., Murri L., et al. High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 14 (2007) 534-539
34. Lopes L.A., Lins Cde M., Adeodato V.G., Quental D.P., de Bruin P.F., Montenegro R.M., et al. Restless legs syndrome and quality of sleep in type 2 diabetes. Diabetes Care 28 (2005) 2633-2636
35. Walters A.S., and The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 10 (1995) 634-642
36. Silber M.H., Ehrenberg B.L., Allen R.P., Buchfuhrer M.J., Earley C.J., Hening W.A., et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 79 (2004) 916-922
37. Sowers J.R., and Vlachakis N. Circadian variation in plasma dopamine levels in man. J Endocrinol Invest 7 (1984) 341-345
38. Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med 5 (2004) 385-391
39. Earley C.J., Connor J.R., Beard J.L., Malecki E.A., Epstein D.K., and Allen R.P. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 54 (2000) 1698-1700
40. Wang X., Wiesinger J., Beard J., Felt B., Menzies S., Earley C., et al. Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome. J Neurol Sci 220 (2004) 59-66
41. Saletu M., Anderer P., Saletu B., Hauer C., Mandl M., Oberndorfer S., et al. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology 41 (2000) 190-199
42. Merlino G., Dolso P., Canesin R., Cancelli I., Valente M., and Gigli G.L. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial. Neuropsychobiology 54 (2006) 195-200
43. Littner M., Kushida C., McDowell Anderson W., Bailey D., Berry R.B., Hirshkowitz M., et al. Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 27 (2004) 557-559
44. Guilleminault C., Cetel M., and Philip P. Dopaminergic treatment of restless legs and rebound phenomenon. Neurology 43 (1993) 445
45. Allen R.P., and Earley C.J. Augmentation of the restless legs syndrome with carbidopa/levodopa. Sleep 19 (1996) 205-213
46. Bogan R.K., Fry J.M., Schmidt M.H., Carson S.W., and Ritchie S. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 81 (2006) 17-27
47. Silber M.H., Girish M., and Izurieta R. Pramipexole in the management of restless legs syndrome: an extended study. Sleep 26 (2003) 819-821
48. Winkelman J.W., and Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med 5 (2004) 9-14
49. Stiasny-Kolster K., Benes H., Peglau I., Hornyak M., Holinka B., Wessel K., et al. Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology 63 (2004) 2272-2279
50. Montplaisir J., Karrasch J., Haan J., and Volc D. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Mov Disord 21 (2006) 1627-1635
51. Allen R., Becker P.M., Bogan R., Schmidt M., Kushida C.A., Fry J.M., et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 27 (2004) 907-914
52. Trenkwalder C., Garcia-Borreguero D., Montagna P., Lainey E., De Weerd A.W., Tidswell P., et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 75 (2004) 92-97
53. Walters A.S., Ondo W.G., Dreykluft T., Grunstein R., Lee D., and Sethi K. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 19 (2004) 1414-1423
54. Partinen M., Hirvonen K., Jama L., Alakuijala A., Hublin C., Tamminen I., et al. Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose finding study-the PRELUDE study. Sleep Med 7 (2006) 407-417
55. Winkelman J.W., Sethi K.D., Kushida C.A., Becker P.M., Koester J., Cappola J.J., et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 67 (2006) 1034-1039
56. Trenkwalder C., Stiasny-Kolster K., Kupsch A., Oertel W.H., Koester J., and Reess J. Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome. Mov Disord 21 (2006) 1404-1410
57. Ferini-Strambi L. Restless legs syndrome augmentation and pramipexole treatment. Sleep Med 3 (2002) S23-S25
58. Walters A.S., Hening W.A., Kavey N., Chokroverty S., and Gidro-Frank S. A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24 (1988) 455-458
59. Earley C.J., Yaffee J.B., and Allen R.P. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome. Neurology 51 (1998) 1599-1602
60. Stiasny K., Wetter T.C., Winkelmann J., Brandenburg U., Penzel T., Rubin M., et al. Long-term effects of pergolide in the treatment of restless legs syndrome. Neurology 56 (2001) 1399-1402
61. Wetter T.C., Stiasny K., Winkelmann J., Buhlinger A., Brandenburg U., Penzel T., et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52 (1999) 944-950
62. Trenkwalder C., Hundemer H.P., Lledo A., Swieca J., Polo O., Wetter T.C., et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 62 (2004) 1391-1397
63. Danoff S.K., Grasso M.E., Terry P.B., and Flynn J.A. Pleuropulmonary disease due to pergolide use for restless legs syndrome. Chest 120 (2001) 313-316
64. Pritchett A.M., Morrison J.F., Edwards W.D., Schaff H.V., Connolly H.M., and Espinosa R.E. Valvular heart disease in patients taking pergolide. Mayo Clin Proc 77 (2002) 1280-1286
65. Zucconi M., Oldani A., Castronovo C., and Ferini-Strambi L. Cabergoline is an effective single-drug treatment for restless legs syndrome: clinical and actigraphic evaluation. Sleep 26 (2003) 815-818
66. Benes H., Heinrich C.R., Ueberall M.A., and Kohnen R. Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 27 (2004) 674-682
67. Tribl G.G., Sycha T., Kotzailias N., Zeitlhofer J., and Auff E. Apomorphine in idiopathic restless legs syndrome: an exploratory study. J Neurol Neurosurg Psychiatry 76 (2005) 181-185
68. Stiasny-Kolster K., Kohnen R., Schollmayer E., Moller J.C., and Oertel W.H. Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Mov Disord 19 (2004) 1432-1438
69. Garcia-Borreguero D., Larrosa O., de la Llave Y., Verger K., Masramon X., and Hernandez G. Treatment of restless legs syndrome with gabapentin: a double-blind, cross-over study. Neurology 59 (2002) 1573-1579
70. Walters A.S., Wagner M.L., Hening W.A., Grasing K., Mills R., Chokroverty S., et al. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16 (1993) 327-332
71. Ondo W.G. Methadone for refractory restless legs syndrome. Mov Disord 20 (2005) 345-348
72. Oertel W.H., Trenkwalder C., Zucconi M., Benes H., Borreguero D.G., Bassetti C., et al. State of the art in restless legs syndrome therapy: practice recommendations for treating restless legs syndrome. Mov Disord 22 (2007) Epub ahead of print 21 May